Mitsubishi Chemical Group Corporation
Notice Regarding Revision of Full-Year Earnings Guidance for the Fiscal Year Ending March 2026
Operating income for the fiscal year ending March 2026 has been revised downward by 60.2% from the previous forecast to 70 billion yen, and net income attributable to owners of parent has been revised down by 62.4% to 47 billion yen.
Key Figures
- Operating Income: 70.0 billion yen (down 60.2% from previous forecast of 176.0 billion yen)
- Net Income Attributable to Owners of Parent: 47.0 billion yen (down 62.4% from previous forecast of 125.0 billion yen)
- Revenue: 3,672.0 billion yen (same as previous forecast)
AI要約
Overview of Earnings Guidance Revision
Mitsubishi Chemical Group Corporation has revised its consolidated full-year earnings guidance for the fiscal year ending March 2026. While revenue and core operating income are maintained at the previous forecast levels of 3,672.0 billion yen and 250.0 billion yen respectively, operating income has been significantly lowered by 60.2% from 176.0 billion yen to 70.0 billion yen. Similarly, net income attributable to owners of parent has been revised downward by 62.4% from 125.0 billion yen to 47.0 billion yen. The main factor behind this substantial downward revision is the additional recognition of extraordinary losses related to structural reforms, including losses linked to the withdrawal from the coke and carbon materials business.
Segment-wise Core Operating Income Forecast
Segmental core operating income forecasts are 65.0 billion yen for Specialty Materials, 189.0 billion yen for Industrial Gases, and minus 1.0 billion yen, minus 1.0 billion yen, and minus 2.0 billion yen for MMA & Derivatives, Basic Materials & Polymers, and Others respectively, unchanged from the previous forecast. As a non-continuing operation, the business transfer of Tanabe Mitsubishi Pharma Corporation was completed on July 1, 2025. Therefore, the current earnings guidance figures are based on continuing operations.
